Get the Stockscreener App
0.821
2.94%
-0.0249
After Hours:
.83
0.009
+1.10%
Applied Dna Sciences Inc stock is traded at $0.821, with a volume of 308.22K.
It is down -2.94% in the last 24 hours and down -30.42% over the past month.
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.
See More
Previous Close:
$0.8459
Open:
$0.818
24h Volume:
308.22K
Relative Volume:
0.28
Market Cap:
$983.46K
Revenue:
$9.00M
Net Income/Loss:
$-7.21M
P/E Ratio:
-1.4927
EPS:
-0.55
Net Cash Flow:
$-7.59M
1W Performance:
-7.86%
1M Performance:
-30.42%
6M Performance:
-91.40%
1Y Performance:
-99.56%
1-Day Range:
$0.8017
$0.8499
1-Week Range:
$0.79
$0.90
52-Week Range:
$0.723
$236.00
Applied Dna Sciences Inc Stock (APDN) Company Profile
Name
Applied Dna Sciences Inc
Sector
Industry
Phone
631-240-8800
Address
50 HEALTH SCIENCES DRIVE, STONY BROOK, NY
Compare APDN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APDN
Applied Dna Sciences Inc
|
0.821 | 983.46K | 9.00M | -7.21M | -7.59M | -0.55 |
|
TMO
Thermo Fisher Scientific Inc
|
403.13 | 159.89B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
189.73 | 142.45B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
491.70 | 37.95B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
106.93 | 30.97B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
148.99 | 26.72B | 15.50B | 1.33B | 2.16B | 7.34 |
Applied Dna Sciences Inc Stock (APDN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-12-21 | Initiated | ROTH Capital | Buy |
| Jan-14-21 | Reiterated | H.C. Wainwright | Buy |
| Dec-18-20 | Reiterated | H.C. Wainwright | Buy |
| Jul-20-20 | Reiterated | H.C. Wainwright | Buy |
| Jul-02-20 | Initiated | H.C. Wainwright | Buy |
| Nov-14-16 | Reiterated | Maxim Group | Buy |
| May-13-16 | Reiterated | Maxim Group | Buy |
| Oct-08-15 | Reiterated | Maxim Group | Buy |
| May-26-15 | Initiated | The Benchmark Company | Speculative Buy |
| Feb-10-15 | Reiterated | Maxim Group | Buy |
| Jan-13-15 | Initiated | Maxim Group | Buy |
View All
Applied Dna Sciences Inc Stock (APDN) Latest News
Applied Dna Sciences Inc (APDN)’s Day in Review: Closing at 0.85, Down by -2.41 - DWinneX
Applied DNA Sciences Inc expected to post a loss of $3.00 a shareEarnings Preview - TradingView
Geode Capital Management LLC Grows Holdings in Applied DNA Sciences, Inc. (NASDAQ:APDN) - Defense World
Applied Dna Sciences Inc (APDN) is an excellent investment, but the stock is overvalued/undervalued right now - uspostnews.com
Applied DNA Sciences (APDN) to Release Quarterly Earnings on Friday - Defense World
Investing in Applied Dna Sciences Inc (APDN) Is Getting More Attractive - knoxdaily.com
Ratios Revealed: Decoding Applied Dna Sciences Inc (APDN)’s Financial Health - DWinneX
Applied DNA Sciences, Inc. (NASDAQ:APDN) Short Interest Update - Defense World
Financial Analysis: Applied Dna Sciences Inc (APDN)’s Ratios Unveil Key Insights - DWinneX
Press Release Distribution & PR Platform - ACCESS Newswire
Analysts Say Applied Dna Sciences Inc (NASDAQ:APDN) Can Really Get To 1.5 In 12 Months - Marketing Sentinel
Applied Dna Sciences Inc [APDN] Investment Appeal on the Rise - knoxdaily.com
Market Highlights: Applied Dna Sciences Inc (APDN) Ends on a High Note at 0.90 - DWinneX
Applied Dna Sciences Inc (APDN) Stock: A 52-Week Tale of Drops and Gains - investchronicle.com
APDN’s earnings estimates: Are they on track to meet expectations? - uspostnews.com
Applied DNA Sciences (APDN) Enhances U.S. Supply Chain for Genetic Medicine Platforms | APDN Stock News - GuruFocus
Applied DNA secures U.S. supply chain for key materials By Investing.com - Investing.com Canada
Applied DNA Sciences (APDN) Enhances U.S. Supply Chain for Genet - GuruFocus
Applied DNA secures U.S. supply chain for key materials - Investing.com
Applied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA | APDN Stock News - GuruFocus
Applied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA - The Joplin Globe
US Biotech Leader LineaRx Transforms DNA Manufacturing with Major Domestic Supply Chain Shift - Stock Titan
APDN stock plunges to 52-week low at $0.89 amid market challenges By Investing.com - Investing.com South Africa
APDN stock plunges to 52-week low at $0.89 amid market challenges - Investing.com Canada
Applied DNA regains compliance with Nasdaq minimum bid price rule - MSN
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Applied DNA regains Nasdaq compliance with bid price By Investing.com - Investing.com South Africa
Applied DNA Sciences Regains Nasdaq Compliance on Minimum Bid Price Rule - MarketScreener
Applied DNA Sciences regains Nasdaq compliance with stock price By Investing.com - Investing.com South Africa
Applied DNA regains Nasdaq compliance with bid price - Investing.com
Applied DNA Sciences regains Nasdaq compliance with stock price - Investing.com
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement - Weatherford Democrat
Applied DNA Overcomes Delisting Threat: Successfully Maintains Nasdaq Standards - Stock Titan
APDN stock plunges to 52-week low at $1.14 amid steep decline - Investing.com Australia
APDN stock plunges to 52-week low at $1.14 amid steep decline By Investing.com - Investing.com South Africa
Applied DNA sets May 22 for virtual shareholder meeting By Investing.com - Investing.com India
Applied DNA sets May 22 for virtual shareholder meeting - Investing.com
Growth or Bubble? APDN’s Unexpected Surge - timothysykes.com
Why Applied DNA Sciences (APDN) Stock Is Rising - Benzinga
Applied DNA refines pharmacogenomics strategy By Investing.com - Investing.com Australia
Applied DNA refines pharmacogenomics strategy - Investing.com
Applied DNA Positions TR8 PGx Testing Service as Pre-Emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug Administration Safety Announcement - ACCESS Newswire
Critical FDA Safety Alert Powers Applied DNA's New Cancer Drug Testing Solution - Stock Titan
APDN stock plunges to 52-week low at $1.63 amid steep decline - Investing.com Canada
Applied Dna Sciences Inc Stock (APDN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.60%
1.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):